PCOS has been renamed in a ‘landmark’ move to improve women’s health

Polycystic ovary syndrome (PCOS) affects 170 million women during their reproductive years alone (Picture: Getty Images)

After more than a decade of campaigns, doctors around the globe have agreed to rename polycystic ovarian syndrome (PCOS).

The condition, which impacts one in eight women — or 3.1 million women and girls in the UK — is characterised by fluctuations in hormones, with impacts on weight, mental health, skin, and the reproductive system.

It’s hoped the new name — polyendocrine metabolic ovarian syndrome (PMOS) — will end misconceptions that the condition is all about ‘cysts’, which has contributed to ‘missed diagnoses and inadequa...